(Q34288923)

1 August 2017

1 reference

title

The use of Shiga-like toxin 1 in cancer therapy (English)

1 reference

1 August 2017

Gariépy J

1

1 reference

1 August 2017

publication date

1 July 2001

1 reference

Critical Reviews in Oncology Hematology

1 August 2017

published in

1 reference

1 August 2017

volume

39

1 reference

1 August 2017

issue

1-2

1 reference

1 August 2017

page(s)

99-106

1 reference

The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Infection by verocytotoxin-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Role of bacterial cytotoxins in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

1 reference

7 January 2021

Structure-function analyses of Shiga toxin and the Shiga-like toxins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

The RNA-N-glycosidase activity of Shiga-like toxin I: kinetic parameters of the native and activated toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Protein toxins with intracellular targets

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Mutations affecting the activity of the Shiga-like toxin I A-chain

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Surfing on a retrograde wave: how does Shiga toxin reach the endoplasmic reticulum?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Inhibition of Shiga-like toxins by brefeldin A

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Importance of glycolipid synthesis for butyric acid-induced sensitization to shiga toxin and intracellular sorting of toxin in A431 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Modification of ricin A chain, by addition of endoplasmic reticulum (KDEL) or Golgi (YQRL) retention sequences, enhances its cytotoxicity and translocation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Role of the disulfide bond in Shiga toxin A-chain for toxin entry into cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Furin-induced cleavage and activation of Shiga toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Insertion and orientation of a synthetic peptide representing the C-terminus of the A1 domain of Shiga toxin into phospholipid membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Ricin A chain utilises the endoplasmic reticulum-associated protein degradation pathway to enter the cytosol of yeast

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Autologous stem cell transplants in lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Where do we stand with respect to the use of peripheral blood progenitor cells?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Expression of Burkitt lymphoma-associated antigen (defined by the monoclonal antibody 38.13) on both normal and malignant germinal-centre B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

CD77: an antigen of germinal center B cells entering apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Neutral glycosphingolipids of the globo-series characterize activation stages corresponding to germinal center B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Monoclonal antibodies against Galα 1 −4Galß 1 −4Glc(Pk, CD77) produced with a synthetic glycoconjugate as immunogen: Reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Neutral glycosphingolipid expression in B-cell neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Differential regulation of glycosphingolipid biosynthesis in phenotypically distinct Burkitt's lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Changes in glycolipid expression in human testicular tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Retroviral transfection of Madin-Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 10(5)- to 10(6)-fold increased cell sensitivity to verocytotoxin. Role of p-glycoprotein in glycolipid synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Probing the surface of eukaryotic cells using combinatorial toxin libraries

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900126-3

7 January 2021

10.1016/S1040-8428(01)00126-3

Identifiers

DOI

1 reference

1 August 2017

1 reference